Wikipedia:Version 1.0 Editorial Team/Pharmacology articles by quality log

This is a log of operations by a bot. The contents of this page are unlikely to need human editing. In particular, links should not be disambiguated as this is a historical record.

August 6, 2025

Renamed

Food and Drug Authority renamed to Indonesian Food and Drug Authority.
TASB (psychedelics) renamed to TASB.

Reassessed

Aceclidine (talk) reassessed. Importance rating changed from Unknown-Class to Mid-Class. (rev · t)
Antidepressants and suicide risk (talk) reassessed. Quality rating changed from Start-Class to B-Class. (rev · t)
Benzathine benzylpenicillin (talk) reassessed. Quality rating changed from Stub-Class to C-Class. (rev · t)

Assessed

Indonesian Food and Drug Authority (talk) assessed. Quality assessed as Redirect-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
TASB (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
Α-Methyletonitazene (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)

August 5, 2025

Renamed

HOT-x (psychedelics) renamed to HOT-x.
TWEETIO (psychedelics) renamed to TWEETIO.
Ψ-PEA (psychedelics) renamed to Ψ-PEA.

Reassessed

Alfaxalone (talk) reassessed. Quality rating changed from Start-Class to B-Class. (rev · t)

Assessed

David Okpako (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
HOT-x (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
TWEETIO (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
Ψ-PEA (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)

August 4, 2025

Reassessed

Federal Food, Drug, and Cosmetic Act (talk) reassessed. Quality rating changed from Redirect-Class to C-Class. (rev · t)
List of cannabinoids (talk) reassessed. Quality rating changed from Unassessed-Class to List-Class. (rev · t)

Assessed

Vatinoxan (talk) assessed. Quality assessed as C-Class. (rev · t) Importance assessed as Low-Class. (rev · t)

August 3, 2025

Reassessed

ARCT-154 (talk) reassessed. Quality rating changed from C-Class to Redirect-Class. (rev · t)
Alixorexton (talk) reassessed. Quality rating changed from Unassessed-Class to Stub-Class. (rev · t)
List of investigational hair loss drugs (talk) reassessed. Quality rating changed from Unassessed-Class to List-Class. (rev · t)

Assessed

INT-777 (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)

Removed

Draft:Prof. Ian Wong Chi Kei (talk) removed.
Draft:黃志基教授 (talk) removed.

August 2, 2025

Renamed

Pleiotropy (drugs) renamed to Drug pleiotropy.

Reassessed

Royalty Pharma (talk) reassessed. Quality rating changed from Unassessed-Class to Start-Class. (rev · t) Importance rating changed from Unknown-Class to Low-Class. (rev · t)

Assessed

2CJP (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
2CLisaB (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
CT-4201 (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
Drug pleiotropy (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
GM-5022 (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
Category:Psychoplastogens (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
SBI-115 (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)

Removed

Legal history of cannabis in the United States (talk) removed.

August 1, 2025

Renamed

Draft:Alixorexton renamed to Alixorexton.

Assessed

CTAP (peptide) (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
Catharanthalog (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
Oxa-noribogaine (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
Rentosertib (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
Velnacrine (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)

July 31, 2025

Renamed

Draft:OM Pharma renamed to OM Pharma.
Omega-3 fatty acid renamed to Omega−3 fatty acid.

Reassessed

1,3-Benzodioxolyl-N-ethylbutanamine (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
1,3-Benzodioxolyl-N-ethylpentanamine (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
1,3-Benzodioxolyl-N-methylpentanamine (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Dr. Reddy's Laboratories (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Huprine Y (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)

Assessed

IHCH-7162 (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
IHCH-7179 (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
Indolylethylamine (talk) assessed. Quality assessed as List-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
Omega−3 fatty acid (talk) assessed. Quality assessed as B-Class. (rev · t) Importance assessed as High-Class. (rev · t)
Pyrrolidinylmethylindole (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
Tetrahydropyridinylpyrrolopyridine (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
Category:Tetrahydropyridinylpyrrolopyridines (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)